Status:
COMPLETED
Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients
Lead Sponsor:
University of Nebraska
Conditions:
Coronary Artery Disease
Myocardial Infarction
Eligibility:
All Genders
19-65 years
Brief Summary
This study investigates hypothesizes that the combination of dobutamine stress echocardiography with dobutamine stress echocardiography with real time perfusion myocardial contrast echocardiography an...
Detailed Description
Primary: To examine the ability of dobutamine stress dobutamine stress echocardiography with real time perfusion (DSE with RTCE) and coronary computed tomographic angiography (cCTA) to detect anatomic...
Eligibility Criteria
Inclusion
- Diabetes mellitus
- Patients undergoing kidney transplant evaluation.
- Currently on hemodialysis
- Adults 19-65 years of age
- Written informed consent from a participant who is deemed medically competent by principal investigator, secondary investigators, or participating personnel as written in II.26 (b)
- Male or female
Exclusion
- Previous history of percutaneous coronary intervention
- Coronary artery bypass surgery
- Prior myocardial infarction or AMI (troponin greater than 1.0) within 48 hours of the test
- Atrial or ventricular arrhythmias that cannot be controlled to heart rates \<65 beats per minute
- Known allergy to iodinated contrast
- Decompensated Congestive Heart failure
- Acute respiratory failure as manifested by signs and symptoms of carbon dioxide retention or hypoxemia
- Pregnant (based on history/information obtained from the patient)
- Possibility that potential subject may be pregnant (based on history/information obtained from the patient)
Key Trial Info
Start Date :
August 25 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2012
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT00726921
Start Date
August 25 2008
End Date
December 21 2012
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198